In this episode, Colin Hayward, CMO of Telix- a commercial-stage biopharmaceutical company, talks about his contribution to the success of Rituximab which culminated in transforming it into a $3 billion radiopharmaceutical giant.

He also shares invaluable insights into the challenges of leadership, the burden of firing people, and the strategic decisions that drive success in the fast-paced world of biotech innovation.

Here's what you are in for:

01:36 Colin's Switch from Medicine to Biotech

04:15 Moving from Treating Patients to Business

05:58 Lessons from Working on Rituxan

10:59 Changing Careers: Consulting, CROs, and Teamwork

23:03 Tips on Hiring and Making a Strong Biotech Team

27:45 The burden of Firing people

About Colin Hayward

Colin Hayward, MD is the Chief Medical Officer at Telix Pharmaceuticals, a company that specializes in radiopharmaceuticals. He has over 20 years of experience in the global pharmaceutical and biotech industries. Colin leads the medical, regulatory, clinical operations, and safety activities at Telix worldwide.

He originally wanted to play football professionally for Brighton Hove Albion, but realized he wasn't good enough at age 12. Switched to field hockey, was academically gifted, loved science, and decided to pursue medicine to help people and dive deeper into science.

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

This podcast episode, Charles drops some real talk on communicating well when hiring people.

He tells a story about how poor communication can really upset candidates and from this story, he gives three tips for hiring managers. This episode emphasizes that it's good to give rejected candidates helpful, positive feedback and to keep talking to them for possible jobs later on rather than ghosting them.

He also shares three tips for hiring managers to protect their reputation and improve their interactions with candidates.

Here's what you are in for:

00:24 Why Protecting Your Reputation Matters

00:44 How Feedback Can Strengthen Your Reputation

02:23 Dealing with Rejection Positively

07:22 Tips for Hiring Managers on Empowerment and Feedback

07:56 Knowing How People Act at Work

15:01 The Need for Empathy and Humility in Hiring

17:40 Wrapping Up: Keeping Your Good Name at Work

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

In this episode, Ben Pais, Senior Vice President at Ariceum Therapeutics, discusses innovative cancer treatments. His company develops drugs that use radiation to combat cancer.

He explains their strategies and adjustments in medical technology, focusing on radiotherapy.

He talks about the challenges of producing and distributing these drugs and the importance of having capable leaders.

Ben also explores future developments in this field and how large pharmaceutical companies acquiring smaller ones can impact the industry.

Here's what you are in for:

00:22 Moving from Clinical Medicine to Pharma

02:00 Starting Out from Surgery to Pharma

04:33 Discovering New Areas in Pharma

08:50 Getting into Radiopharmaceuticals

16:02 Growing in a Radiopharmaceutical Career

19:25 Understanding Radiopharmaceuticals: Simple to Complex

24:34 Finding Your Way in the Radiopharmaceutical Field

33:57 What's Next for Radiopharmaceuticals and Career Tips

About Ben Pais

Ben is a doctor with 25 years in the life science field. He knows about urology, cardiology, and radiation oncology. He has handled clinical trials (phase I-IV), medical affairs, drug safety, getting products to market, launching products, and early sales steps. Since 2019, he's been a certified Pharmaceutical Physician NVFG. In 2020, he started at Ipsen as the Global Development Lead for Radiopharmaceuticals. Later, he moved to Ariceum.

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

In this episode, Charles talks about how to craft authentic and genuine stories that can sell yourself and stand out from the rest. He points out that many resumes lack persuasive pitches and unique stories, so he offers 5 tips on creating these narratives. He stresses the need for authenticity and alignment with one's CV and interview responses.

He also discusses typical mistakes, like not showing the hidden benefits or linking past experiences to what future employers are looking for.

Here's what you are in for:

01:03 A Sneak Peek at Making Your CV

01:36 How to Make Sales Stories That Stick

04:18 Knowing Your Audience is Your First Step to Win

05:14 Being Specific on How to Make Stories Catchy

10:42 Using Lessons for Future Wins

11:26 The Secret to Job Applications

12:45 Building a Strong Professional Image

13:09 More Than Crafting a CV But Growing Your Career Chances

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://discera-search.circle.so/

In this episode, Charles talks with Riccardo Canevari, the managing director and CEO of Radiopharm Theranostics, a company that is innovating the way we see cancer. They talked about his leadership journey in transitioning from leading 110k employees to a 3-man startup team. He also discusses launching innovative cancer treatments such as Luziterra and BluVicto and the challenges of selling them. He also highlights the importance of mission-driven work in biotech and the promise of radiopharmaceuticals in cancer treatment.

Here's what you are in for:

00:00 Ricardo's Journey From Milan to Pharma Leader

00:19 Family's Influence in Early Life

03:25 Ricardo's Career Path from Chemistry to Pharma

05:38 Highs and Lows in Pharma Industry

05:51 Leadership Lessons

10:27 Taking the new role as the head of Radio Pharm

17:59 Building a 3-man start up team

30:24 Reflecting on Leadership and Advancement

35:41 The Future of Radiotherapy

About Riccardo Canevari

Riccardo is an experienced leader in specialty pharma, cancer care, and radiopharmaceuticals. He served as the Chief Commercial Officer at Advanced Accelerator Applications, a leading company owned by Novartis. There, he led commercial strategies in around 20 countries. His main focus was on expanding the market for Lutathera and preparing for the launch of Lu-PSMA 617 to treat advanced prostate cancer. Before this, Riccardo held top positions at Novartis Oncology. He oversaw the successful introduction of breast cancer drugs like KISQALI and PIQRAY. He also gained extensive experience from different roles at Novartis Pharma and Ethicon/Johnson & Johnson.

Connect with Riccardo:

LinkedIn: https://www.linkedin.com/in/riccardo-canevari-7239931/

Website: https://www.radiopharmtheranostics.com/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the

biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/

Website:https://discera-search.circle.so/

In this episode, we're exploring the latest in radiotherapy, especially radioligand therapy for cancer treatment. Charles spotlights some promising trials coming up in 2024 that involve companies like Ymabs, Marianao Oncology, and many more fighting hard-to-treat cancers with new techniques and talks about big deals in the industry, like when Point Pharma and Ray's bio were bought. These deals show how important radiotherapy is in business and strategy.

Looking ahead, Charles sees a bright future for radiotherapy, with better supply chains possibly making treatments cheaper and more accessible.

Here's what you are in for:

00:00 Introduction to New Radiotherapy Methods

00:28 Understanding Radiotherapy Today

02:14 Early Trials in Radiotherapy

07:54 Key Trials and Their Effects on the Industry

12:17 The Future of Radiotherapy

13:21 Final Thoughts and What's Next

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

• LinkedIn:https://www.linkedin.com/in/charles-spence-clinical/
• Website:https://discera-search.circle.so/

In this episode, we talk about ADCs or antibody-drug conjugates with Ilaria Contis, a VP at ADC Therapeutics. This Swiss company is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs). It is known for being a one-stop-shop for ADC development, handling everything from research to selling their products.

Ilaria shares about how ADCs (antibody-drug conjugates) are transforming cancer treatment, opportunities and challenges in ADC tech, and why global experience matters in pharma careers.

Here's what you are in for:

01:14 – Getting Into Medicine

09:56 – Interest in ADCs

11:25 – ADC’s History and Recent Developments

21:13 – Business Development Perspective on ADCs

25:38 – Expanding Beyond Hematology

31:02 – US vs. Europe in Pharma and Biotech Careers

40:28 – Inspiring the Next Generation

About Ilaria

Ilaria Contis is a pharmaceutical developer from Tuscany, Italy, where she spent her childhood. With a background in medicine and a strong drive for research, Ilaria was inspired by the groundbreaking work of Nobel Prize laureate Rita Levi-Montalcini to pursue a career in the medical field. Her journey led her to the United States, where she immersed herself in clinical research and eventually found her niche in the pharmaceutical industry, particularly focusing on the development of Antibody-Drug Conjugates (ADCs).

Connect with Ilaria:

• LinkedIn: https://www.linkedin.com/in/ilaria-conti-581bb06/
• Website: https://www.adctherapeutics.com/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

• LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
• Website: https://discera-search.circle.so/

In this episode, Charles covers the steps before applying, the application process, and how to negotiate your salary. He also explores the reasons behind the discomforts that may arise during these conversations and provides practical tips and strategies to help you navigate salary negotiations confidently.

Here's what you are in for:

00:00 - Introduction

01:49 - Salary Negotiation Topic Introduction

03:14 - Pre-Application Advice

08:11 - Research and Self-Value Assessment

10:45 - Application Form and Recruiter Interaction

13:05 - Interview Phase Strategy

15:15 - Salary Negotiation

ABOUT CHARLES

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles on:

• Linkedin: linkedin.com/in/charles-spence-clinical
• Website: https://discera-search.circle.so/